Pharmaceutical

Delivery and manufacturing hurdles remain in the cell and gene therapy

Panellists discuss opportunities and challenges in cell and gene therapies at the Advanced Therapies conference in London, UK.

Mar 22, 2024 - 00:00
Delivery and manufacturing hurdles remain in the cell and gene therapy
Panellists discuss opportunities and challenges in cell and gene therapies at the Advanced Therapies conference in London, UK.
Read the original article

Tags:

Previous Article

Capstan secures $175m Series B funds for CAR-T therapy

Next Article

Delivery tech remains challenging with gene therapies for brain disorders

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Pivotal bioVenture raises the stakes in biotech and pharmaceutical support

Pivotal bioVenture raises the stakes in biotech and pha...

Dec 18, 2023

Opinion: A bipartisan opportunity to strengthen America’s pandemic security

Opinion: A bipartisan opportunity to strengthen America...

Jul 12, 2023

AstraZeneca’s Tagrisso gains approval in Canada for NSCLC

AstraZeneca’s Tagrisso gains approval in Canada for NSCLC

Jul 16, 2024